DraftKings Joins $41M Lobbying Push Amid Rising Tax and Regulatory Headwinds

What happened

DraftKings and FanDuel have jointly funded a $41 million federal Super PAC for lobbying efforts in 2026, with DraftKings contributing $17.5 million. This move aligns with the DeepValue report's warning about escalating state tax regimes, such as Illinois' progressive hike, which threaten DraftKings' margins and earnings stability. The report highlights DraftKings' financial challenges, including negative EPS, high valuation multiples, and a recent guidance cut due to outcome volatility and heavy investment spend. Management's aggressive capital allocation, previously focused on M&A and share buybacks, now extends to political lobbying as a defensive strategy to shape favorable regulations. This initiative underscores the costly and uncertain nature of mitigating regulatory risks that could cap long-term profitability.

Implication

The lobbying effort confirms DraftKings' acute awareness of tax and regulatory threats, such as potential Illinois-style hikes in other states, which the DeepValue report identifies as a major headwind. While it may temporarily delay adverse regulations, it increases operating expenses without assured benefits, straining already tight margins amid negative earnings. For investors, this reinforces the need to closely monitor state-level legislative developments, as they directly impact unit economics and cash flow, key factors in the report's bear case with an implied value of $26. The news does not alter the fundamental recommendation to wait for clearer evidence of margin expansion or a lower entry price, as lobbying's efficacy remains uncertain. Therefore, maintaining a cautious stance aligns with the report's advice to avoid the stock until tax headwinds are better managed or valuations become more attractive.

Thesis delta

The DeepValue report's thesis advises waiting due to unproven growth initiatives and tax headwinds; the lobbying news confirms management's focus on regulatory risks but does not change the core uncertainties around earnings volatility and margin expansion. It emphasizes that regulatory outcomes remain a key swing factor, yet lobbying adds cost pressures without guaranteeing success, reinforcing the need for patience. Thus, the thesis remains unchanged: investors should seek lower prices or tangible improvements in EBITDA margins before committing capital.